Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BMRA Biomerica, Inc. daily Stock Chart
BMRA [NASD]
Biomerica, Inc.
Healthcare | Medical Instruments & Supplies | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.25 Insider Own1.30% Shs Outstand9.53M Perf Week-10.94%
Market Cap27.16M Forward P/E- EPS next Y-0.34 Insider Trans0.00% Shs Float7.47M Perf Month-6.86%
Income-2.30M PEG- EPS next Q-0.08 Inst Own1.30% Short Float0.31% Perf Quarter17.28%
Sales5.20M P/S5.22 EPS this Y-56.80% Inst Trans-6.07% Short Ratio0.61 Perf Half Y11.72%
Book/sh0.42 P/B6.79 EPS next Y-32.00% ROA-44.20% Target Price6.25 Perf Year-24.00%
Cash/sh0.09 P/C30.18 EPS next 5Y- ROE-54.30% 52W Range1.60 - 3.94 Perf YTD67.65%
Dividend- P/FCF- EPS past 5Y-34.30% ROI-35.20% 52W High-27.66% Beta1.43
Dividend %- Quick Ratio2.00 Sales past 5Y-3.00% Gross Margin26.70% 52W Low78.12% ATR0.23
Employees39 Current Ratio3.90 Sales Q/Q-7.10% Oper. Margin-43.70% RSI (14)41.60 Volatility8.58% 7.78%
OptionableNo Debt/Eq0.00 EPS Q/Q-93.20% Profit Margin-44.10% Rel Volume1.25 Prev Close2.92
ShortableYes LT Debt/Eq0.00 EarningsAug 29 BMO Payout- Avg Volume38.68K Price2.85
Recom- SMA20-12.00% SMA50-1.39% SMA20010.57% Volume48,426 Change-2.40%
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Aug-21-19 08:19AM  Republic of Colombias food and drug regulatory agency grants clearance for Biomericas colorectal cancer screening test to be sold in Colombia GlobeNewswire
Jul-25-19 11:33AM  When Can We Expect A Profit From Biomerica, Inc. (NASDAQ:BMRA)? Simply Wall St.
Jun-19-19 02:28PM  Can You Imagine How Chuffed Biomerica's (NASDAQ:BMRA) Shareholders Feel About Its 141% Share Price Gain? Simply Wall St. +9.22%
Jun-05-19 08:19AM  Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. GlobeNewswire +7.97%
Apr-25-19 10:06AM  Could Biomerica, Inc.'s (NASDAQ:BMRA) Investor Composition Influence The Stock Price? Simply Wall St.
Apr-22-19 11:00AM  BMRA: Revenue Slows Although Potential Growth Catalysts on the Horizon. Further Pipeline Progress Zacks Small Cap Research
Apr-16-19 09:18AM  Biomerica Announces Third Quarter Financial Results GlobeNewswire
Apr-08-19 08:19AM  Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) GlobeNewswire +7.57%
Mar-12-19 08:45AM  LD Micro Virtual Conference Is Live, March 12th and 13th ACCESSWIRE
Feb-21-19 02:49PM  What You Must Know About Biomerica, Inc.s (NASDAQ:BMRA) Beta Value Simply Wall St. +6.25%
Feb-05-19 08:19AM  Biomerica Announces Updates for H. Pylori Clinical Studies GlobeNewswire
Jan-22-19 02:42PM  An Intrinsic Calculation For Biomerica, Inc. (NASDAQ:BMRA) Shows Its 32.14% Undervalued Simply Wall St.
Jan-21-19 11:00AM  BMRA: Q219 Results: Asia Continues to Accelerate, Europe Rebounds, U.S. Still Weak But Could Return to Growth Zacks Small Cap Research
Jan-15-19 08:19AM  Biomerica Announces Second Quarter Financial Results GlobeNewswire
Nov-28-18 08:19AM  Medline and Biomerica sign agreement for distribution of Biomericas colorectal screening test to help identify an early warning sign of colorectal cancer GlobeNewswire
Nov-16-18 08:55AM  Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences Fundamental Analysis, Key Performance Indications GlobeNewswire
07:30AM  Can We See Significant Insider Ownership On The Biomerica Inc (NASDAQ:BMRA) Share Register? Simply Wall St.
Nov-07-18 09:42AM  Biomericas Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud GlobeNewswire +10.36%
Oct-22-18 01:15PM  BMRA: Q1 2019: Asia Strong, Europe & U.S. Weak. Revenue up 13% QoQ But Down 12% yoy. Expense Control Minimizes Op Loss. Zacks Small Cap Research +8.70%
Oct-16-18 08:30AM  Biomerica Reports 1st Quarter Fiscal 2019 Financials GlobeNewswire -10.48%
Sep-26-18 12:00PM  Is Biomerica Inc (NASDAQ:BMRA) A Financially Sound Company? Simply Wall St.
Sep-07-18 10:00AM  BMRA: Legacy Biz Slows in Q4. Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and were intrigued) Zacks Small Cap Research
Aug-30-18 08:19AM  Biomerica Announces Fiscal Year End 2018 Financial Results GlobeNewswire -6.28%
Aug-02-18 08:19AM  Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea GlobeNewswire
Jun-25-18 08:19AM  Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy GlobeNewswire
May-31-18 08:26PM  When Can We Expect A Profit From Biomerica Inc (NASDAQ:BMRA)? Simply Wall St. +5.17%
May-10-18 05:55PM  Should You Be Concerned About Biomerica Incs (NASDAQ:BMRA) Shareholders? Simply Wall St.
Apr-19-18 09:45AM  BMRA: Q3 2018 Results: Asia Remains Strong While U.S., Europe Slip. Encouraged By Robustness of InFoods Study Design Zacks Small Cap Research
08:19AM  Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board GlobeNewswire
Apr-17-18 03:01PM  Does Biomerica Incs (NASDAQ:BMRA) Past Performance Indicate A Stronger Future? Simply Wall St.
09:00AM  Biomerica Announces Third Quarter Financial Results GlobeNewswire
Mar-08-18 08:19AM  Mexicos COFEPRIS (Mexicos equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer GlobeNewswire
Mar-01-18 06:11PM  Biomerica Inc (NASDAQ:BMRA): Is Breakeven Near? Simply Wall St.
Jan-23-18 09:45AM  BMRA: Moving Price Target to $7/Share With Inclusion of InFoods Zacks Small Cap Research
Jan-19-18 10:54AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 Capital Cube
Jan-16-18 09:18AM  Biomerica Announces Second Quarter Financial Results; Sales Up 12.7% for the Quarter GlobeNewswire -8.89%
Jan-10-18 08:19AM  China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer GlobeNewswire +20.45%
Jan-09-18 08:43AM  Biomerica Inc (NASDAQ:BMRA): Poised For Long-Term Success? Simply Wall St.
Jan-08-18 08:19AM  Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT) GlobeNewswire
Jan-01-18 06:55PM  Is Biomerica Inc (NASDAQ:BMRA) Thriving Or Barely Surviving In The Healthcare Sector? Simply Wall St.
Dec-25-17 11:35AM  Does Biomerica Incs (NASDAQ:BMRA) Earnings Growth Make It An Outperformer? Simply Wall St.
Dec-07-17 04:23PM  What You Must Know About Biomerica Incs (BMRA) Financial Health Simply Wall St.
Nov-20-17 08:19AM  Biomerica Announces Enrollment of First Patient for H. Pylori Clinical Studies at the University of Southern California ACCESSWIRE
Nov-13-17 05:25PM  Who Are The Major Shareholders In Biomerica Inc (BMRA)? Simply Wall St.
Nov-07-17 08:19AM  Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019 GlobeNewswire +7.72%
Oct-20-17 11:00AM  BMRA: Q1 Results Solid. H. Pylori Test Piques Interest Zacks Small Cap Research
Oct-17-17 08:37AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q1, 2018 By the Numbers : October 17, 2017 Capital Cube
08:19AM  Biomerica Reports 1st Quarter Fiscal 2018 Financials GlobeNewswire
Sep-20-17 09:30AM  Analyst Sees >35% Upside in Shares of Biomerica, Inc. ACCESSWIRE
Sep-12-17 08:19AM  Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test GlobeNewswire +6.62%
Sep-06-17 01:00PM  BMRA Looking To Capitalize On Strong OUS Growth With Expanded Distribution Zacks Small Cap Research
Aug-31-17 10:34AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q4, 2017 By the Numbers : August 31, 2017 Capital Cube
Aug-30-17 01:03PM  Biomerica, Inc. :BMRA-US: Earnings Analysis: 2017 By the Numbers : August 30, 2017 Capital Cube
08:19AM  Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year GlobeNewswire
Aug-16-17 08:19AM  Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company GlobeNewswire
May-23-17 07:29AM  Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017 Marketwired
Apr-18-17 02:00PM  BMRA: Base Business Bouncing Back With Three Quarters of Sequential Growth Zacks Small Cap Research
09:46AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2017 By the Numbers : April 18, 2017 Capital Cube
Apr-17-17 08:19AM  Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months Marketwired
Mar-09-17 08:19AM  Biomerica to present at the 29th Annual ROTH conference on March 13, 2017 Marketwired
Jan-26-17 10:30AM  BMRA: Analysis of IBS Drugs Indicates Unmet Need for Alternative Therapies Zacks Small Cap Research
Jan-21-17 01:04PM  BIOMERICA INC Financials
Jan-18-17 11:24AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q2, 2017 By the Numbers : January 18, 2017 Capital Cube
11:24AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q2, 2017 By the Numbers : January 18, 2017
08:19AM  Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter Marketwired
Jan-17-17 04:18PM  BIOMERICA INC Files SEC form 10-Q, Quarterly Report
Nov-30-16 09:00AM  Biomerica to Present at the 9th Annual LD Micro Main Event Accesswire
Oct-20-16 09:00AM  BMRA: Base Business Bounces Back, InFoods Continues To Attract Whos-Who of IBS
Oct-19-16 09:22AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q1, 2017 By the Numbers : October 19, 2016
Oct-18-16 07:57AM  Biomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year Marketwired
Oct-17-16 04:18PM  BIOMERICA INC Files SEC form 10-Q, Quarterly Report
Oct-04-16 07:57AM  Biomerica Highlights Recent Scientific Reports Indicating Increased Prevalence of IBS Marketwired
Sep-12-16 02:50PM  BIOMERICA INC Files SEC form 8-K, Other Events
Sep-06-16 10:45AM  Progress of InFoods Prompts Upward Revision to Valuation Zacks Small Cap Research
10:45AM  BMRA: Progress of InFoods Prompts Upward Revision to Valuation
07:47AM  Biomerica to Present at 18th Annual Rodman & Renshaw Global Investment Conference Marketwired
Aug-30-16 09:29AM  Biomerica Announces Year End Results Marketwired
Aug-29-16 04:18PM  BIOMERICA INC Files SEC form 10-K, Annual Report
Aug-24-16 08:19AM  Biomerica Approved for Listing on the Nasdaq Capital Market Marketwired
Aug-10-16 09:25AM  Biomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product Marketwired
08:10AM  BIOMERICA INC Files SEC form 8-K, Other Events
Jul-25-16 07:47AM  Biomerica Forms Strategic Advisory Board and Expands Scientific Advisory Board Marketwired
Jul-18-16 07:47AM  Biomerica Adds Dr. Mark Sirgo to Board of Directors Marketwired
Jul-13-16 10:20AM  BMRA: More Positive Clarity on InFoods' FDA Pathway
Jul-11-16 07:47AM  FDA Determines That Biomerica's Proposed InFoods(R) IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study Marketwired
Jun-22-16 11:02AM  Biomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers : June 22, 2016
Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It primarily offers its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the point-of-care and in-hospital/clinical laboratories worldwide. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy, which is in clinical studies to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CANO FRANCISDirectorOct 26Option Exercise0.7525,00018,750166,736Oct 26 02:25 PM
BARBIERI ALLENDirectorOct 19Option Exercise0.7525,00018,750160,289Oct 19 04:29 PM
Emerson JaneDirectorOct 05Option Exercise0.7525,00018,75071,000Oct 10 04:49 PM
open in yahoo | open in reuters | open in google